Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Regencell Bioscience ( (RGC) ) has provided an update.
On June 30, 2025, Regencell Bioscience Holdings Limited announced the appointment of Ms. Margaret Hoor Han Lo as an independent director, following the resignation of Mr. Paul J. Niewiadomski. Ms. Lo brings over 30 years of experience in real estate investments and will serve on several key committees. Mr. Niewiadomski resigned for personal reasons and will continue in an advisory role, with no disagreements cited with the company.
More about Regencell Bioscience
Regencell Bioscience Holdings Limited operates within the bioscience industry, focusing on innovative healthcare solutions. The company is incorporated under the laws of the Cayman Islands and is based in Hong Kong.
Average Trading Volume: 3,304,204
Technical Sentiment Signal: Buy
Current Market Cap: $8.6B
Find detailed analytics on RGC stock on TipRanks’ Stock Analysis page.